Work

Abstract 3911: Use of ALK inhibitors in patients with non-lung malignancies bearing ALK alteration prolongs treatment duration.

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-3911

Authors: Vitor Abreu de Goes, Miguel Zugman, Koral Shah, Ali Moradi, Salvador Jaime-Casas, Yu Jun Li, Daniela V. Castro, Benjamin Mercier, Jadon Fann, JoAnn Hsu, George Zhang, Vicki Doctor, Amber Moran, Maurie Markman, Alexander Chehrazi-Raffle, Charles Nguyen, Sumanta Kumar Pal

Institutions: City Of Hope National Medical Center, City of Hope, Beckman Research Institute, Cancer Treatment Centers of America

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148774121

Cites:

Cited by:

Related to: